Clinical Trial Update: Evaluation of the 2-year AVF Utilization Rate

View source ↗

Summary

A ClinicalTrials.gov update on the two-year arteriovenous fistula utilization rate for dialysis access, sponsored by Université Paul Sabatier of Toulouse; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: University Paul Sabatier of Toulouse | Conditions: Dialysis Access Dysfunction, Fistulae | Status: ACTIVE_NOT_RECRUITING